Using an online pharmacy to buy meds? It's buyer beware, FDA says
It might be tempting to buy prescription medication online, but buyers should beware, the U.S. Food and Drug Administration warns.
Nov 18, 2022
1
11
It might be tempting to buy prescription medication online, but buyers should beware, the U.S. Food and Drug Administration warns.
Nov 18, 2022
1
11
Another major pharmacy chain has offered billions to settle claims for its role in the opioid epidemic.
Nov 15, 2022
0
2
For nearly 10 years, Stacie Dusetzina, Ph.D., a Vanderbilt University professor of Health Policy and Ingram Professor of Cancer Research, has focused her research on one core policy issue that has been of interest to lawmakers ...
Nov 3, 2022
0
2
President Joe Biden is highlighting his administration's efforts to lower prescription drug costs on Friday as part of his three-state Western tour this week, as he confronts a sobering inflation report in the waning weeks ...
Oct 14, 2022
0
4
Medicare open enrollment starts soon, but 7 in 10 Medicare beneficiaries say they don't compare Medicare plans during this period, according to a 2021 analysis by KFF, a health policy nonprofit.
Oct 12, 2022
0
33
In the first known study of its type, an international team of researchers evaluated whether high research and development (R&D) costs explain high drug prices in the United States.
Sep 26, 2022
1
82
An automated process that combines natural language processing and machine learning identified people who inject drugs (PWID) in electronic health records more quickly and accurately than current methods that rely on manual ...
Sep 22, 2022
0
13
Misusing over-the-counter medications can have dangerous consequences, but recent social media trends encouraging this could be downright deadly for gullible teens, the U.S. Food and Drug Administration warned Thursday.
Sep 19, 2022
0
52
Active participation in internet forums has the potential to provide life-changing social benefits and well-being for people who are in remission from opioid use disorder
Sep 6, 2022
0
4
Federal health regulators remain unconvinced about the benefits of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, even as they prepare to give its drugmaker a rare second opportunity ...
Sep 2, 2022
0
2